2025医药行业合规与信用建设大会即将在京启幕

Core Viewpoint - The "2025 Pharmaceutical Industry Compliance and Credit Construction Conference" aims to establish a compliance credit ecosystem across the entire pharmaceutical industry chain, focusing on sustainable development and supporting the Healthy China strategy [1][2]. Group 1: Conference Overview - The conference will take place from November 29 to 30 in Beijing, organized by the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber [1]. - The core theme of the conference is "Compliance and Credit, Safeguarding Long-term Development" [1]. Group 2: Key Participants and Mechanisms - A new three-dimensional dialogue mechanism involving "medical institutions, chambers of commerce, and pharmaceutical companies" will be introduced to promote compliance consensus [2]. - Leaders from major companies such as Yangtze River Pharmaceutical Group, Hengrui Medicine, and Merck China will engage in high-level discussions with clinical institution leaders [2]. - The Compliance and Credit Working Committee of the All-China Federation of Industry and Commerce Pharmaceutical Industry Chamber has been established, and an action plan for industry self-regulation will be released [2]. Group 3: Solutions and Innovations - Leading global institutions will present cutting-edge solutions to empower corporate transformation during the conference [3]. - Top law firms and consulting teams will provide insights on compliance essentials and share practical tools for financial and tax compliance [3]. - AI and big data applications will be showcased to enhance compliance in academic promotion [3]. Group 4: Significant Announcements - The conference will unveil two major group standards in the compliance field and launch a compliance credit information sharing platform [4]. - A report on "Safety Risk Prevention for Chinese Pharmaceutical Enterprises Going Global" will be released to support internationalization efforts [4]. Group 5: Focus on High-Quality Development - The conference will explore the coexistence of compliance and innovation, with discussions involving top medical institution managers and pharmaceutical company compliance officers [5]. - Experts will discuss the integration of real-world value assessment in medical insurance and the drive for new productive forces in academic promotion [5].